Deutsche Bank
CORV

Deutsche Bank’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Deutsche Bank’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,800
Closed -$11K – 5558
2018
Q4 		$11K Sell
4,800
-15,300
-76% -$50.9K ﹤0.01% 4863
2018
Q3 		$81K Buy
20,100
+3,800
+23% +$16.8K ﹤0.01% 4571
2018
Q2 		$62K Sell
16,300
-14,500
-47% -$37.8K ﹤0.01% 4711
2018
Q1 		$71K Buy
30,800
+1,500
+5% +$2.37K ﹤0.01% 4638
2017
Q4 		$45K Buy
+29,300
New +$47.1K ﹤0.01% 4477
2017
Q3 		– Sell
-4,169
Closed -$18K – 5199
2017
Q2 		$18K Buy
+4,169
New +$15.1K ﹤0.01% 4584
2017
Q1 		– Sell
-500
Closed -$1K – 5199
2016
Q4 		$1K Hold
500
– – ﹤0.01% 4863
2016
Q3 		$1K Buy
500
+100
+25% +$365 ﹤0.01% 4866
2016
Q2 		$2K Buy
+400
New +$1.92K ﹤0.01% 5103
2015
Q3 		– Sell
-14,599
Closed -$137K – 5428
2015
Q2 		$137K Buy
14,599
+12,920
+770% +$120K ﹤0.01% 4077
2015
Q1 		$15K Buy
+1,679
New +$16.1K ﹤0.01% 4737
2014
Q3 		– Sell
-815
Closed -$6K – 6197
2014
Q2 		$6K Sell
815
-605
-43% -$4.57K ﹤0.01% 5605
2014
Q1 		$11K Buy
1,420
+1,020
+255% +$8.21K ﹤0.01% 5015
2013
Q4 		$2K Sell
400
-17,899
-98% -$93.8K ﹤0.01% 5219
2013
Q3 		$64K Buy
18,299
+17,899
+4,475% +$40.7K ﹤0.01% 4580
2013
Q2 		$0 Buy
+400
New +$802 ﹤0.01% 5378

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Deutsche Bank's CORV Position: Q1 2019 in Review

Deutsche Bank sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2019, closing a stake of 4,800 shares — an estimated $11K sold.

Deutsche Bank first reported a position in CORV in Q2 2013 and held it in 16 quarters. The position peaked at $137K in Q2 2015. 40 funds tracked by Wall St. Rank hold CORV as of Q1 2019.

  • Deutsche Bank reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2019 after selling out during the quarter.
  • Deutsche Bank sold 4,800 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2019, an estimated $11K.
  • Deutsche Bank first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 16 quarters.
  • Deutsche Bank's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $137K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2019.

Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.